European Journal of Clinical Pharmacology · 2019 · 45 citations · 15 references
MedicinePharmacologyPharmacotherapyHemostasisPharmacodynamicsPharmacokinetic VariabilityAnticoagulant ManagementAnticoagulation ManagementAtrial FibrillationThrombosisThrombosis ManagementThrombosis PreventionAnticoagulant-related Bleeding ComplicationsAtrial Fibrillation BiomarkersAtrial Fibrillation PathophysiologyAtrial Fibrillation Risk AssessmentBleeding Risk Reduction
15
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text